![](/img/cover-not-exists.png)
P-283 * Impact of second-line cetuximab-containing therapy in patients with KRAS wild type metastatic colorectal cancer: results from ITACa trial
Passardi, A., Scarpi, E., Fontana, A., Cavanna, L., Ruscelli, S., Turci, D., Lorusso, V., Mucciarini, C., Tassinari, D., Ragazzini, A., Valgiusti, M., Ulivi, P., Frassineti, G. L., Amadori, D.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.280
Date:
June, 2015
File:
PDF, 64 KB
english, 2015